Absorb Bioresorbable Vascular Scaffold
Related Content
May 30, 2024 — Biotronik announced the presentation of the 12-month results from the BIONETIC-I study this week at LINC ...
February 14, 2024 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, today announced that ...
October 30, 2023 — Abbott announced late-breaking data from the LIFE-BTK clinical trial evaluating the Esprit BTK ...
September 5, 2023 — New data from the BIOMAG-I first-in-human trial shed light on the vascular healing process following ...
March 16, 2023 — Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator, presented the latest results of the ...
October 11, 2022 — Efemoral Medical, developer of advanced interventional bioresorbable therapies, announced that it has ...
September 28, 2022 — In the "TCT Innovation" session Prof. Michael Haude, BIOMAG-I Coordinating Clinical Investigator ...
September 27, 2022 — BIOTRONIK announced the presentation of new full-cohort 2-year BIOSOLVE-IV data. In a poster ...
December 16, 2020 — Efemoral Medical announced the first-in-human (FIH) use of the its Efemoral bioresorbable vascular ...
September 3, 2020 — Abbott today announced the start of the LIFE-BTK clinical trial to evaluate the safety and ...